Skip to main content
User picture
Academic title: M.Sc.
Phone: +420 585632089
Groups: IMTM, LEM, STAFF

About me

Scientist specializing in molecular and translational medicine, with a diverse background encompassing oncology, microbiology/virology, fertility, and genetics. Primary focus lies in unraveling the intricate mechanisms underlying various diseases, particularly the connection between virus infections and cancer.  Member of Virology and molecular carcinogenesis research group.

Specialties: Molecular and translational medicine, Oncology, Virology, Molecular carcinogenesis and HPV-driven cancers.

Responsibility for next-genome sequencing, virus-driven infections, and carcinogenesis research.

https://www.linkedin.com/in/hana-jaworek-1577a4a1/

https://orcid.org/0000-0001-6263-0049

Journals

Pitfalls of commercially available HPV tests in HPV68a detection. PLOS One. 2019, 14(8), e0220373, ISSN: 1932-6203, PMID: 31381580,  PDF.
The absence of high-risk human papillomavirus in Czech non-small cell lung cancer cases. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2020, 164(1), 71-76, ISSN: 1213-8118, PMID: 30631209,
JAWOREK, H., V. KOUDELÁKOVÁ, J. DRÁBEK, J. VRBKOVÁ, B. ZBORILOVA, I. OBORNA, J. BREZINOVA, R. MAREK, K. HUML, P. VANEK, M. HAJDÚCH
A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV: Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs. The Journal of Molecular Diagnostics. 2018, 20(6), 849-858, ISSN: 1525-1578, PMID: 30165205,  PDF.